INTRODUCTION
changes in demographics of the population, particularly in China and India, which have the largest population sizes. The direct costs of hip fracture is expected to rise from USD 9.5 billion in 2018 to USD 15 billion in 2050 (a 1.59-fold increase). To keep the total number of hip fractures constant over time, a 2-3% decrease in the incidence rate of hip fracture is required annually. They concluded that, despite the availability of better diagnosis, treatment, and prevention for fracture over recent years, hip fracture remains a key public health issue in Asia and that healthcare policy should aim to reducethe burden of hip fracture in Asia. 19 However, studies on the incidence and mortality of refractures following an initial osteoporotic fracture are restricted owing to their comparatively rare incidences and the need for a large sample size.
Therefore, the objectives of this research were: 1) to determine the incidence of osteoporotic refractures and fracture locations and 2) to assess related mortality rates over a median follow up of 3 years using a nationwide claims database.
MATERIALS AND METHODS

Data source
This research used information from the 2002 to 2013 claims database of the Korean National Health Insurance (KNHI). The KNHI gathers cohort information representing the population of the country. The sample cohort covers 1025340 subjects (2.2% of the total population of 47851928) through random stratification according to sex, age, and income level. The database provides reimbursement data for each medical service, including fundamental demographics of the patients, clinic or hospital identifiers, disease code, expenses incurred, health screening outcomes, individual and family health history, health behaviors, and death-related data. 20 This study was approved by the Institutional Review Board (IRB) of Chung-Ang University Hospital [IRB No. C2014086(1282)]. The requirement for informed consent was waived as this study was based on review of data that were regularly gathered.
Subjects
Selection criteria were: 1) those aged 50 years or older who were diagnosed with osteoporotic fractures, including the hip, spine, humerus, and distal radius, in the national database from 2007 to 2012; 2) those who were followed up until 2013 with original fractures reported from 2007 to 2012; and 3) those who were followed up for at least 1 year ( Fig. 1 
Definition of refracture and survival duration
Refracture was classified as a fracture of bone in one of four initial components (hip, humerus, spine, and wrist) that occurred after 6 months (180 days) based on the last claim date. 26 The re-fracture was defined after a 6-month untreated period using the same operational definition as described previously. 27, 28 Survival duration was defined as the length from the first fracture date to the date of death between 2007 and 2012.
Mortality after osteoporotic fractures in patients
NHIS data were combined with National Statistical Office domestic mortality data to determine survival for each patient during the follow-up period after osteoporotic fracture. From the index date of the first refracture event, the mortality rate of patients with refracture was calculated.
Adjustment of comorbidity index and disability
Medical comorbidity was based on the modified Charlson's Comorbidity Index, which was calculated as the amount of points given for disease circumstances conditions as follows: one point for myocardial infarction, deep vein thrombosis, congestive heart failure, peripheral vascular disease, dementia, arthritis, chronic obstructive pulmonary disease, diabetes mellitus, or ulcer; two points for stroke or cancer; and three points for liver cirrhosis. Thus, possible total scores ranged from 0 to 15, with higher scores indicating poorer health status. 29 In terms of disability, its class (physical disability or all-cause disability) and severity (grade 1: ordinary, grade 1-2: serious, grade 3-6: mild) were obtained from the NHIS database. Disability was assessed by the accountable physician according to particular guidelines developed by the Korean government.
Statistical analyses
To evaluate the relationship between recurrence of osteoporotic fracture and death, the time from incidence to death was calculated, and recurrence from incidence of the final episode to death was calculated. A life table was used to calculate the cumulative incidence of refracture. Cumulative incidence was described as the likelihood of a specific case occurring, such as the occurrence of a specific disease. It was calculated as the amount of topics at the start of the research, separating the amount of new refractures over a period of time. The risk of mortality was calculated using Cox proportional hazards regression. A life table was also used to calculate the rate of survival. All data analyses were performed using SAS statistical package version 9.4 (SAS Institute, Cary, NC, USA).
RESULTS
A total of 18956 first-time instances of osteoporotic fracture were reported between 2007 and 2012, with a median follow-up of 3.1 years (range, 1 to 7 years). Demographic features of each fracture site and the refracture states of patients are summarized in Table 1 .
There were 4641 (24.50%) male patients and 14315 (75.50%) female patients. A total of 724 (3.80%) patients showed serious impairment related with the severity of the disease, and 2999 (15.80%) patients died during the follow-up period. Of 18956 patients, 2941 (15.50%) had at least one refracture. There were statistically significant differences in sex, age, and mortality between the refracture group and the non-refracture group ( Table 1 , Fig. 1 ). Osteoporotic fracture in the spine had the highest number of cases (n=8600, 45.40%), followed by wrist fracture (n=6243, 32.90%), fracture in the humerus (n=829, 4.40%), and hip fracture (n=3284, 17.30%). Of 2941 patients with refractures, 1116 (37.95%), 815 (27.71%), 677 (23.02%), and 333 (11.32%) events were associated with the spine, hip, wrist, and humerus, respectively. The incidences of re-fracture according to the first fracture site were 12.83% (1103/8600) in spine and 22.50% (739/3284) in hip. The incidence of wrist refracture in a previous wrist fracture was 6.63% (414/6243), and the frequency of humeral re-fracture involving a previous humeral fracture was 35.83% (297/829) ( Table 2) .
Mortality in the re-fracture group (63.5/1000 person-years) was higher than that in the non-refracture group (44.5/1000 person-years) during the study period (Table 3 ). After adjusting for age, sex, income, and comorbidity index, the mortality rate in patients with re-fracture was 1.4 times [hazard ratio (HR): 1.4, 95% confidence interval (CI): 1.26-1.55, p<0.001] higher than that in patients without re-fracture over a median follow-up of 3 years (Fig. 2) .
According to the site of first fracture, mortality risk was decreased in the order of hip (HR: 1.68, p<0.001), humerus (HR: 1.41, p<0.001), spine (reference), and wrist (HR: 0.52, p<0.001).
In addition, the mortality risks according to the site of first refracture (reference=non-refracture) were decreased in the order of hip (HR=1.52, p<0.001), spine (HR=1.09, p=0.329), humerus (HR=0.93, p=0.722), and wrist (HR=0.69, p=0.072) ( Table 4 ).
Adults >85 years of age showed greater danger of re-fracture than those aged between 50 and 54 years (HR: 1.43, 95% CI: 1.17-1.76, p<0.001). The risk of re-fracture was higher in female (HR: 1.37, 95% CI: 1.30-1.44, p<0.001) than in male. 
DISCUSSION
Although attempts have been made to prevent secondary fractures in patients with osteoporotic fracture over the past several centuries, information about the incidence, morbidity, mortality, and financial burden associated with secondary fractures is still limited for patients with osteoporotic fractures. Thus, this study determined the incidence and mortality of osteoporotic refractures based on information from domestic claims for health insurance. During the study period with a median follow-up of 3 years (range, 1 to 7 years), the incidence of refractures among complete osteoporotic fractures was 15.5% (2941/18956 patients). Incidences rates of refractures in the spine, hip, wrist, and humerus were 37.95%, 27.71%, 23.02%, and 11.32%, respectively. Cumulative mortality rates for nonrefracture and re-fracture groups at 1 year of follow up were 7.2% and 9.1%, respectively. During the study period, cumulative mortality was higher in the re-fracture group than that in the non-refracture group. After adjusting for age, sex, income, and comorbidity, the mortality rate was 1.2 times greater in patients with re-fracture than that in patients without re-fracture (Model 2, HR: 1.20, 95% CI: 1.08-1.34, p<0.001). Risk ratios for hip, humerus, and wrist refractures were 1.68, 1.41, and 0.52, respectively. Adults >85 years of age had a greater risk of refracture than those aged between 50 and 54 years (HR: 1.43, 95% CI: 1.17-1.76, p<0.001), and the risk of refracture was greater in females (HR: 1.37, 95% CI: 1.30-1.44, p<0.001) than in males. Hsiao, et al. 30 determined the incidence of osteoporotic fracture in patients over 65 years of age using the National Health Insurance Database. They indicated that within the first year of original fracture, 45% experienced complete refractures. Although the overall incidence of secondary fracture depended on follow-up periods, 50% of cases showed refractures within 3 years after the primary fracture. 27, 31, 32 In the present study, the incidence of re-fracture during follow up corresponded with the results of other studies. The incidence of refracture improved significantly up to 2 years in this research, and it decreased gradually to a plateau. Of all refractures, 21% and 55% occurred at 1 and 2 years, respectively. Considering such trends in patients with primary osteoporotic fractures, early prevention appears mandatory to minimize the incidence of refracture.
Nakayama, et al. 33 performed a historical cohort study of all patients aged at least 50 years who had a 6-month history of minimal trauma fracture and presented to the emergency departments of a tertiary hospital with and without a fracture liaison service. They reported a 30% reduction in the rate of refracture at the fracture liaison service hospital and a 40% reduction in major refractures (hip, spine, femur, pelvis, or humerus).
Klotzbuecher, et al. 34 performed a meta-analysis and revealed that past history of wrist fracture not only increases the risk of subsequent wrist fracture [odds ratio (OR): 3.3], but also increases the risk of hip fracture (OR: 1.9). Similarly, past history of hip fracture increased the risk of subsequent hip fracture (OR: 2.3) in peri-or post-menopausal females. A common fracture, irrespective of its location, reduced the danger of subsequent fracture, including pooled vertebral and non- vertebral fractures (OR: 2). 34 van Staa, et al. 35 used British cohort information to evaluate the incidence of subsequent fractures. They found that a previous tibia, fibula, ankle, femur, hip, radius, ulna, rib, or humerus fracture increased the risk of subsequent fracture, with corresponding ORs ranging from 2 to 3. Specifically, patients with a history of radius or ulna fracture had the highest risk of humerus fracture (OR: 5.8, 95% CI: 5.5-6.1). 35 Overall, patients with osteoporotic fracture reported greater hip, spine, proximal humerus, and distal radius mortality. These results often matched secondary fractures in main fractures. Bliuc, et al. 36 performed a long-term follow-up cohort study to investigate the mortality of osteoporotic fractures in patients above 60 years of age. They reported 2.99-fold and 1.91-fold increases in mortality in male and female patients with refractures, respectively. Refracture within 5 years of an initial fracture significantly increased the mortality. Furthermore, mortality was moderately increased within 10 years. In the present study, the mortality rate in patients with refracture was 1.2 times higher than that in the non-refracture group (HR: 1.20, 95% CI: 1.08-1.34, p<0.001) after adjusting for age, sex, income, and comorbidity index. During a follow-up duration of 4 years, risks of mortality rate (HR: 1.27 at 1 year, 1.25 at 2 years, 1.29 at 3 years, 1.10 at 4 years, and 0.99 at 5 years) were higher in the re-fracture group than those in the non-refracture group.
Hsiao, et al. 30 found that important risk factors are hip (HR= 1.45), spine (HR=1.59), female sex (HR=1.41), and age over 85 years (HR=1.26). Our findings also showed that advanced age and female sex were risk factors for refracture. However, the frequency of refracture in this study was the highest at the humerus and hip joints depending on the primary fracture site. The incidence of humerus-related refracture was 3.7 times greater than in the hip and 2 times greater than in the spine.
This study has several limitations. First, bone mineral density data or laboratory data, such as vitamin D, calcium, body mass index, smoking/alcohol status, or caffeine use, were not considered because this study was based on the National Claims Registry database. Second, although the operative definition of this study excluded pathologic fractures, it was impossible to clinically diagnose any disease associated fractures. Therefore, fracture incidence might have been overestimated. Third, mortality due to a specific medical condition or non-medical usage was not analyzed. Additional research studies investigating refracture and mortality based on large-scale registry data are needed. Fourth, trends in refracture could be compared to other studies. The secular trend of re-fracture in this study cannot be generalized due to the study period and the characteristics of the database. Finally, cox-regression analysis was used to analyze the effect of refracture on mortality. However, competing risk analysis was not performed. In addition, statistical processing was difficult due to the use of claim data. Nevertheless, cohort data from the NHIS were used to analyze refracture patterns for a nationally representative population. Reporting the incidence according to different scenarios of major osteoporotic refractures would be meaningful.
In summary, in this nationwide study, the incidence of osteoporotic re-fracture was 15.5%. The mortality rate in refracture patients was found to be 1.2 times higher than that in non-refracture patients over a median follow-up of 3 years.
